38383421|t|Parkinson's disease-derived alpha-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
38383421|a|Parkinson's disease (PD) is a common age-related neurodegenerative disorder characterized by the aggregation of alpha-Synuclein (alphaSYN) building up intraneuronal inclusions termed Lewy pathology. Mounting evidence suggests that neuron-released alphaSYN aggregates could be central to microglial activation, which in turn mounts and orchestrates neuroinflammatory processes potentially harmful to neurons. Therefore, understanding the mechanisms that drive microglial cell activation, polarization and function in PD might have important therapeutic implications. Here, using primary microglia, we investigated the inflammatory potential of pure alphaSYN fibrils derived from PD patients. We further explored and characterized microglial cell responses to a chronic-type inflammatory stimulation combining PD patient-derived alphaSYN fibrils (FPD), Tumor necrosis factor-alpha (TNFalpha) and prostaglandin E2 (PGE2) (TPFPD). We showed that FPD hold stronger inflammatory potency than pure alphaSYN fibrils generated de novo. When combined with TNFalpha and PGE2, FPD polarizes microglia toward a particular functional phenotype departing from FPD-treated cells and featuring lower inflammatory cytokine and higher glutamate release. Whereas metabolomic studies showed that TPFPD-exposed microglia were closely related to classically activated M1 proinflammatory cells, notably with similar tricarboxylic acid cycle disruption, transcriptomic analysis revealed that TPFPD-activated microglia assume a unique molecular signature highlighting upregulation of genes involved in glutathione and iron metabolisms. In particular, TPFPD-specific upregulation of Slc7a11 (which encodes the cystine-glutamate antiporter xCT) was consistent with the increased glutamate response and cytotoxic activity of these cells toward midbrain dopaminergic neurons in vitro. Together, these data further extend the structure-pathological relationship of alphaSYN fibrillar polymorphs to their innate immune properties and demonstrate that PD-derived alphaSYN fibrils, TNFalpha and PGE2 act in concert to drive microglial cell activation toward a specific and highly neurotoxic chronic-type inflammatory phenotype characterized by robust glutamate release and iron retention.
38383421	0	19	Parkinson's disease	Disease	MESH:D010300
38383421	28	43	alpha-synuclein	Gene	6622
38383421	82	94	inflammatory	Disease	MESH:D007249
38383421	110	120	neurotoxic	Disease	MESH:D020258
38383421	143	162	Parkinson's disease	Disease	MESH:D010300
38383421	164	166	PD	Disease	MESH:D010300
38383421	180	218	age-related neurodegenerative disorder	Disease	MESH:D019636
38383421	255	270	alpha-Synuclein	Gene	6622
38383421	272	280	alphaSYN	Gene	6622
38383421	326	340	Lewy pathology	Disease	MESH:D005598
38383421	390	398	alphaSYN	Gene	6622
38383421	491	508	neuroinflammatory	Disease	MESH:D000090862
38383421	659	661	PD	Disease	MESH:D010300
38383421	760	772	inflammatory	Disease	MESH:D007249
38383421	791	799	alphaSYN	Gene	6622
38383421	821	823	PD	Disease	MESH:D010300
38383421	824	832	patients	Species	9606
38383421	916	928	inflammatory	Disease	MESH:D007249
38383421	951	953	PD	Disease	MESH:D010300
38383421	954	961	patient	Species	9606
38383421	970	978	alphaSYN	Gene	6622
38383421	988	991	FPD	Chemical	-
38383421	994	1021	Tumor necrosis factor-alpha	Gene	7124
38383421	1023	1031	TNFalpha	Gene	7124
38383421	1037	1053	prostaglandin E2	Chemical	MESH:D015232
38383421	1055	1059	PGE2	Chemical	MESH:D015232
38383421	1085	1088	FPD	Chemical	-
38383421	1103	1115	inflammatory	Disease	MESH:D007249
38383421	1134	1142	alphaSYN	Gene	6622
38383421	1189	1197	TNFalpha	Gene	7124
38383421	1202	1206	PGE2	Chemical	MESH:D015232
38383421	1208	1211	FPD	Chemical	-
38383421	1288	1291	FPD	Chemical	-
38383421	1326	1338	inflammatory	Disease	MESH:D007249
38383421	1359	1368	glutamate	Chemical	MESH:D018698
38383421	1535	1553	tricarboxylic acid	Chemical	MESH:D014233
38383421	1719	1730	glutathione	Chemical	MESH:D005978
38383421	1735	1739	iron	Chemical	MESH:D007501
38383421	1799	1806	Slc7a11	Gene	23657
38383421	1855	1858	xCT	Gene	23657
38383421	1894	1903	glutamate	Chemical	MESH:D018698
38383421	2077	2085	alphaSYN	Gene	6622
38383421	2162	2164	PD	Disease	MESH:D010300
38383421	2173	2181	alphaSYN	Gene	6622
38383421	2191	2199	TNFalpha	Gene	7124
38383421	2204	2208	PGE2	Chemical	MESH:D015232
38383421	2289	2299	neurotoxic	Disease	MESH:D020258
38383421	2313	2325	inflammatory	Disease	MESH:D007249
38383421	2360	2369	glutamate	Chemical	MESH:D018698
38383421	2382	2386	iron	Chemical	MESH:D007501
38383421	Positive_Correlation	MESH:D015232	MESH:D018698
38383421	Positive_Correlation	MESH:D007249	7124
38383421	Positive_Correlation	MESH:D018698	23657
38383421	Association	MESH:D007501	MESH:D020258
38383421	Association	MESH:D007249	6622
38383421	Association	MESH:D010300	6622
38383421	Association	MESH:D005598	6622
38383421	Positive_Correlation	MESH:D018698	MESH:D020258
38383421	Association	MESH:D007501	MESH:D015232
38383421	Positive_Correlation	MESH:D018698	7124
38383421	Association	MESH:D000090862	6622
38383421	Association	MESH:D007501	7124
38383421	Positive_Correlation	MESH:D015232	MESH:D007249

